Phase III Trial of Febuxostat in Korea Gout Patients
NCT00821392 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 181
Last updated 2009-01-13
Summary
This study was designed to evalute the efficacy and safety of Febuxostat after oral administration to patientd with gout in Korea
Conditions
Interventions
- DRUG
-
Febuxostat
Sponsors & Collaborators
-
SK Chemicals Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2007-09-30
- Completion
- 2007-09-30
More Related Trials
-
Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
NCT00174967 ·Status: COMPLETED ·Phase: PHASE2
-
Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
NCT00102440 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
NCT01736514 ·Status: COMPLETED ·Phase: PHASE3
-
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Term Safety of Febuxostat in Subjects With Gout.
NCT00174941 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
NCT01078389 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
NCT06139393 ·Status: COMPLETED ·Phase: PHASE3
-
Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
NCT03372200 ·Status: COMPLETED ·Phase: PHASE3
-
Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 ·Status: COMPLETED ·Phase: PHASE2
-
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
NCT06622603 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
NCT02128490 ·Status: COMPLETED ·Phase: PHASE2
-
A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients
NCT05815901 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout
NCT05007392 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
NCT01510769 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers
NCT01563432 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
NCT06414837 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
NCT05513976 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
NCT06603142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults
NCT05347498 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
NCT05109936 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy
NCT04069325 ·Status: UNKNOWN ·Phase: NA
-
Effect of Febuxostat on Blood Pressure
NCT01496469 ·Status: COMPLETED ·Phase: PHASE2